AB183492

重组Anti-FRS2抗体[EPR14724]

Anti-FRS2 antibody [EPR14724]

RabMAb
Recombinant
了解详情

Be the first to review this product! Submit a review

(12 Publications)

Rabbit Recombinant Monoclonal FRS2 antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 12 publications.

查看别名

Fibroblast growth factor receptor substrate 2, FGFR substrate 2, FGFR-signaling adaptor SNT, Suc1-associated neurotrophic factor target 1, SNT-1, FRS2

4 Images

Flow Cytometry (Intracellular) - Anti-FRS2 antibody [EPR14724] (AB183492)

Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-FRS2 antibody [EPR14724] (AB183492)

Intracellular flow cytometric analysis of 2% paraformaldehyde-fixedSH-SY5Y cells labeling FRS2 with ab183492 at 1/20 dilution (red), compared to aRabbit monoclonal IgG isotype control (green), followed byGoat anti rabbit IgG (FITC) secondary antibody at 1/150 dilution.

Supplier Data

Immunoprecipitation - Anti-FRS2 antibody [EPR14724] (AB183492)

Western blot analysis of FRS2 in Human fetal brain lysate immunoprecipitated using ab183492 at 1/50 dilution (Lane 1). Lane 2 : TBS instead of Human fetal brain lysate.

Secondary : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution.

All lanes:

Immunoprecipitation - Anti-FRS2 antibody [EPR14724] (ab183492)

Predicted band size: 57 kDa

false

Supplier Data

Western blot - Anti-FRS2 antibody [EPR14724] (AB183492)

All lanes:

Western blot - Anti-FRS2 antibody [EPR14724] (ab183492) at 1/10000 dilution

Lane 1:

Human fetal brain lysate at 20 µg

Lane 2:

HeLa cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution

Predicted band size: 57 kDa

false

Supplier Data

Western blot - Anti-FRS2 antibody [EPR14724] (AB183492)

All lanes:

Western blot - Anti-FRS2 antibody [EPR14724] (ab183492) at 1/2000 dilution

All lanes:

SH-SY5Y cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution

Predicted band size: 57 kDa

false

不同偶联物与剂型 (1)

Carrier free

Anti-FRS2 antibody [EPR14724] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR14724

亚型

IgG

不含载体蛋白

反应种属

Human

应用

WB, IP, Flow Cyt (Intra)

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style

left-column

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50 - 1/70", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/20", "FlowCytIntra-species-notes": "<a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody." } } }

style

left-column

产品详情

Patented technology
Our RabMAb^® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb^® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production

For more information, read more on recombinant antibodies.

style

left-column

性能和储存信息

形式

Liquid

纯化工艺

Affinity purification Protein A

存储溶液

pH: 7.2 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA

运输条件

Blue Ice

分装信息

Upon delivery aliquot

储存信息

Avoid freeze / thaw cycle

style

left-column

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

FRS2 also known as Fibroblast growth factor receptor substrate 2 functions as an adaptor protein in cellular signal transduction. This protein with a molecular mass of approximately 60 kDa plays a critical role in linking receptor tyrosine kinases specifically FGFR (Fibroblast Growth Factor Receptor) to downstream signaling pathways. FRS2 primarily expresses in various tissues with notable expression in neural and epithelial cells. Its function involves phosphorylation and the recruitment of downstream signaling molecules which propagate cellular response signals.

Biological function summary

FRS2 integrates into several signaling complexes that regulate key cellular processes. It acts as a scaffold protein creating platforms for the assembly of signaling complexes such as those involving Grb2 (Growth factor receptor-bound protein 2) and Sos (Son of Sevenless). These complexes mediate processes related to cell differentiation proliferation and survival. The protein's ability to anchor and direct these signaling molecules highlights its importance within cellular mechanisms where it influences signaling cascades leading to specific cellular outcomes.

Pathways

The role of FRS2 is essential in the FGFR and MAPK/ERK pathways. Within these pathways FRS2 interacts closely with proteins like FGFR facilitating their activation and consequent downstream signaling events. Through these interactions the protein influences pathways involved in developmental processes and cellular maintenance. FRS2 by enabling FGFR signal transduction significantly impacts cellular responses to external growth stimuli making it an important player in normal cellular function and development.

Abnormalities in FRS2 function or expression link to certain pathologies including cancer and neurological disorders. For instance overactivation of FRS2-mediated signaling pathways can contribute to oncogenic processes leading to uncontrolled cell growth and proliferation. Furthermore mutations affecting FRS2 interaction with FGFR have implications in developmental disorders characterized by neural defects. Understanding FRS2 connections in these diseases helps in identifying potential therapeutic targets for treatment interventions.

style

left-column

style

left-column

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

Visit the General protocols
Visit the Troubleshooting

style

left-column

靶点信息

Adapter protein that links activated FGR and NGF receptors to downstream signaling pathways. Plays an important role in the activation of MAP kinases and in the phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, in response to ligand-mediated activation of FGFR1. Modulates signaling via SHC1 by competing for a common binding site on NTRK1.

See full target information FRS2

style

left-column

文献 (12)

Recent publications for all applications. Explore the full list and refine your search

Signal transduction and targeted therapy 10:299 PubMed40935839

2025

Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Lu,Minjuan Hu,Yikai Zhao,Tianqing Chu,Wei Zhang,Yijia Zhou,Xinlei Cai,Jun Wu,Liang Hu,Chunlei Shi,Liwen Xiong,Aiqin Gu,Huimin Wang,Yanwei Zhang,Yuqing Lou,Runbo Zhong,Zhiqiang Gao,Hongyu Liu,Chao Zhou,Yingli Wu,Liang Zhu,Hua Zhong,Hongbin Ji,Baohui Han

Archives of endocrinology and metabolism 69:e240410 PubMed40834280

2025

miR-590-5p mediates mitochondrial respiration, proliferation, and apoptosis in thyroid carcinoma cells via fibroblast growth factor receptor substrate 2.

Applications

Unspecified application

Species

Unspecified reactive species

Penghui Wang,Xiaoli Hou,Wei Sun,Jiajie Chen,Yasen Cao,Hong Cheng

The Journal of clinical investigation 135: PubMed40014401

2025

Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Saireudee Chaturantabut,Sydney Oliver,Dennie T Frederick,Jiwan J Kim,Foxy P Robinson,Alessandro Sinopoli,Tian-Yu Song,Yao He,Yuan-Chen Chang,Diego J Rodriguez,Liang Chang,Devishi Kesar,Meilani Ching,Ruvimbo Dzvurumi,Adel Atari,Yuen-Yi Tseng,Nabeel Bardeesy,William R Sellers

Nature communications 15:3805 PubMed38714664

2024

FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yuanli Zhen,Kai Liu,Lei Shi,Simran Shah,Qin Xu,Haley Ellis,Eranga R Balasooriya,Johannes Kreuzer,Robert Morris,Albert S Baldwin,Dejan Juric,Wilhelm Haas,Nabeel Bardeesy

International journal of molecular sciences 24: PubMed37569547

2023

Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Won-Sik Shin,Si Won Oh,Han Na Park,Jae Hoon Kim,Seung-Taek Lee

The Journal of biological chemistry 299:102729 PubMed36410439

2022

Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of action.

Applications

Unspecified application

Species

Unspecified reactive species

Jocelyn Chan,Joyce Chan,Lily Shao,Scott S Stawicki,Victoria C Pham,Rob W Akita,Marc Hafner,Lisa Crocker,Kebing Yu,James T Koerber,Gabriele Schaefer,Laetitia Comps-Agrar

Evidence-based complementary and alternative medicine : eCAM 2022:6235771 PubMed36387361

2022

TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yurong Song,Guiju Zhou,Enxue Song,Lei Zhan,Qingyuan Wang,Hui Song,Jingxian Xia,Lin Cong

Journal of oncology 2022:4537343 PubMed36304988

2022

Long Noncoding RNA XIST Promotes Resistance to Lenvatinib in Hepatocellular Carcinoma Cells via Epigenetic Inhibition of NOD2.

Applications

Unspecified application

Species

Unspecified reactive species

Anqi Duan,Hui Li,Wenlong Yu,Yongjie Zhang,Lei Yin

British journal of cancer 127:1239-1253 PubMed35864158

2022

LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Xie,Kunpeng Du,Wei Liu,Chunshan Liu,Baiyao Wang,Yunhong Tian,Rong Li,Xiaoting Huang,Jie Lin,Haifeng Jian,Jian Zhang,Yawei Yuan

Cancer discovery 12:1378-1395 PubMed35420673

2022

EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qibiao Wu,Yuanli Zhen,Lei Shi,Phuong Vu,Patricia Greninger,Ramzi Adil,Joshua Merritt,Regina Egan,Meng-Ju Wu,Xunqin Yin,Cristina R Ferrone,Vikram Deshpande,Islam Baiev,Christopher J Pinto,Daniel E McLoughlin,Charlotte S Walmsley,James R Stone,John D Gordan,Andrew X Zhu,Dejan Juric,Lipika Goyal,Cyril H Benes,Nabeel Bardeesy

View all publications

style

left-column

style

left-column

style

right-column

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂，为您科研的每一步提供支持。若我们的产品未能达到预期性能，我们向您提供 Abcam Product Promise 保障。

详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

重组Anti-FRS2抗体[EPR14724]